EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study

Jian Li, Yuefeng Hu, Chengcheng Wang, Hongkai Liu, Zijie Zhang, Songliu Hu, Jianli Ma, Shilong Liu, Jianyu Xu, Lei Yao iD

Technology in Cancer Research & Treatment · 2026-08 · 25

DOI: 10.1177/15330338261508400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 14.11.2026. Verfasst von Jian Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Radiomics, Lung Neoplasms, Magnetic Resonance Imaging, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite advances in lung cancer management, overall survival (OS) remains limited due to tumor heterogeneity. This study aimed to evaluate the potential of pretreatment MRI-based radiomics, combined with clinical parameters, for prognostic assessment in non-small cell lung cancer (NSCLC).

Methods

This retrospective, single-center study included 70 consecutive patients with NSCLC who underwent pretreatment MRI and were randomly divided into a training cohort (n = 49) and an internal validation (n = 21) cohort. Radiomic features were extracted and filtered for reproducibility (ICC ≥ 0.75), followed by feature selection using univariate Cox regression and 10-fold cross-validated least absolute shrinkage and selection operator Cox (LASSO-Cox) regression within the training cohort. The training-derived Radiom model was evaluated in both cohorts. In exploratory full-cohort analyses, a clinical-only model (Clinical), the Radiom model (Radiomics), and a combined clinical-radiomics model (ClinRadiom) were compared using the concordance index (C-index), time-dependent area under the curve (AUC), calibration, decision-curve analysis, and 1,000-resample bootstrap internal validation.

Results

Among the 70 patients, 47 deaths occurred and 23 observations were censored. The median follow-up was 2.98 years (95% CI, 2.44-4.87). Seven radiomic features were retained to construct the Radiom score. The Radiom model achieved C-indices of 0.722 and 0.671 in the training and internal validation cohorts, respectively, with 1-, 2-, and 3-year AUCs of 0.653, 0.848, and 0.774 in the internal validation cohort. In exploratory full-cohort comparisons, ClinRadiom showed the highest apparent C-index (0.743; 95% CI, 0.662-0.823) and an optimism-corrected C-index of 0.733, with 1-, 2-, and 3-year AUCs of 0.700, 0.921, and 0.889, respectively. Adding Radiom to the Clinical model significantly improved model fit (likelihood-ratio p < 0.001).

Conclusion

The Radiom and ClinRadiom models showed potential for OS risk stratification in NSCLC. MRI-based radiomics may provide complementary non-invasive prognostic information, although validation in larger multicenter cohorts is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiomicsLung NeoplasmsMagnetic Resonance ImagingCarcinoma, Non-Small-Cell LungHumansFemalePrognosisMaleMiddle AgedAgedRetrospective StudiesNeoplasm StagingROC Curve

Stichwörter der Autor:innen

Magnetic resonance imagingNon-small cell lung cancerOverall survivalPrognosisRadiomics

Autor:innen und Institutionen

  • Department of Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
  • Department of Radiotherapy, Hainan Cancer Hospital, Haikou, Hainan, China.
  • Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

ORCID-Profile: Lei Yao

Zitieren

APA

Li, J., Hu, Y., Wang, C., Liu, H., Zhang, Z., Hu, S., Ma, J., Liu, S., Xu, J., & Yao, L. (2026). MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261508400

Vancouver

Li J, Hu Y, Wang C, Liu H, Zhang Z, Hu S, et al. MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261508400

BibTeX
@article{Li2026,
  author = {Li, Jian and Hu, Yuefeng and Wang, Chengcheng and Liu, Hongkai and Zhang, Zijie and Hu, Songliu and Ma, Jianli and Liu, Shilong and Xu, Jianyu and Yao, Lei},
  title = {MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261508400}
}
Kostenlos starten →